Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Europe For Pharma Mid-Caps: Tough But Necessary

Mar 26 2012

Related Content

Mediator Scandal Provokes Flurry of French Health Reforms But Impact Is Hard To Gauge Until The Dust Settles

Aug 01 2011

European Price Cuts, Restructuring Charges, Hit France's Ipsen in 2011

Mar 01 2012

Germany’s Pricing Revolution: Why The World Should Be Watching

Feb 24 2012

European Austerity Drama May Likely Spur The Pace But Not Change The Strategic Plot Line For Pharma

Dec 05 2011

Related Companies

GSK plc

Gilead Sciences, Inc.

Bristol Myers Squibb Company

Biogen, Inc.

Elan Corporation

Acorda Therapeutics, Inc.

InterMune, Inc.

Les Laboratoires Servier

Almirall SA

Ipsen SA

Additional Topics

Europe Strategy Business Strategies BioPharmaceutical

More from Global Vision

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window